ANTI- A1 LECTIN. - COFEPRIS Registration 1038R2020 SSA
Access comprehensive regulatory information for ANTI- A1 LECTIN. (ANTI- A1 LECTIN.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1038R2020 SSA and manufactured by KABLA COMERCIAL, S.A. DEC.V.. The device was registered on August 04, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PARADETERMINARELSUBGRUPODESANGREA1. AGENTES DE DIAGNรSTICO PARA USO INVITRO, PARA USO EXCLUSIVO ENLABORATORIOS CLรNICOS ร DE GABINETE.
TO DETERMINE the blood subgroupA1. DIAGNOSTIC AGENTS FOR INVITRO USE, FOR EXCLUSIVE USE IN CLINICAL LABORATORIES OR CABINET.

